Utility of interphase FISH to stratify patients into cytogenetic risk categories at diagnosis of AML in an Eastern Cooperative Oncology Group (ECOG) clinical trial (E1900)

Leukemia Research

Volumn 31, Issue 5, 2007, Pages 605-609

  Vance, Gail H ^a   Kim, Haesook ^b   Hicks, Gary A ^c   Cherry, Athena M ^d   Higgins, Rodney ^e   Hulshizer, Rachael L ^c   Tallman, Martin S ^f   Fernandez, Hugo F ^g   Dewald, Gordon W ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ABBOTT NORTHWESTERN HOSPITAL   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g UNIVERSITY OF MIAMI   (United States)

Author keywords

Acute myeloid leukemia; Cytogenetics; FISH

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CHROMOSOME 5Q; CHROMOSOME 7Q; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME ADDITION; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 8; CHROMOSOME TRANSLOCATION 9; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INTERPHASE; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL;

ACUTE DISEASE; ANTINEOPLASTIC AGENTS; BONE MARROW; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOMES, HUMAN; DNA PROBES; DNA, NEOPLASM; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; KARYOTYPING; LEUKEMIA, MYELOID; MIDDLE AGED; PROGNOSIS;

EID: 34147121394     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.07.026     Document Type: Article

References (15)

1. Slovak M.L., Kopecky K.J., Cassileth P.A., Harrington D.H., Theil K.S., Mohamed A., et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study. Blood 96 (2000) 4075-4083
2. Sinclair P.B., Green A.R., Grace C., and Nacheva E.P. Improved sensitivity of bcr-abl detection: a triple-probe three-color fluorescence in situ hybridization system. Blood 90 (1997) 1395-1402
3. Fleischman E.W., Reshmi S., Sokova O.I., Kirichenko O.P., et al. Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignancies. Cancer Genet Cytogenet 108 (1999) 166-170
4. Cox M.C., Panetta P., Venditti A., Del Poeta G., et al. Comparison between conventional banding analysis and FISH screening with an AML-specific set of probes in 260 patients. Hematol J 4 (2003) 263-270
5. ISCN. In: Mitelman F. (Ed). An International System for Human Cytogenetic Nomenclature (1995), S. Karger, Basel
6. Brockman S.R., Paternoster S.F., Ketterling R.K., and Dewald G.W. New highly sensitive fluorescence in situ hybridization method to detect PML/RARA fusion in acute promyelocytic leukemia. Cancer Genet Cytogenet 145 (2003) 144-151
7. Dewald G.W., Brockman S.R., and Paternoster S.F. Molecular cytogenetic studies for hematological malignancies. In: Finn W.G., and Peterson L.C. (Eds). Hematopathology in Oncology (2004), Kluwer Academic Publications 69-112
8. Thurston V.C., Ceperich T.M., Vance G.H., and Heerema N.A. Detection of monosomy 7 in bone marrow by fluorescence in situ hybridization: a study of Fanconi anemia patients and review of the literature. Cancer Genet Cytogenet 109 (1994) 154-160
9. Flactif M., Lau J.L., Preudhomme C., and Fenaux P. Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes. Leukemia 8 (1994) 1012-1018
10. Arif M., Tanaka K., Camodaran C., Asou H., Kyo T., Dohy H., et al. Hidden monosomy 7 in acute myeloid leukemia and myelodysplastic syndrome detected by interphase fluorescence in situ hybridization. Leuk Res 20 (1996) 709-716
11. Cherry A.M., Brockman S.R., Paternoster S.F., Hicks G.A., Neuberg D., et al. Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study. Leuk Res 27 (2003) 1085-1090
12. Frohling S., Skeline S., Liebisch, Scholl C., Schlenk R.F., Dohner H., et al. Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia. J Clin Oncol 20 (2002) 2480-2485
13. Dierlamm J., Stul M., Vranckx H., Michaux L., Weghuis D.E., Speleman F., et al. FISH identifies inv(16) (p13q22) masked by translocations in three cases of acute myeloid leukemia. Genes Chromos Cancer 22 (1998) 87-94
14. Aventin A., Espadaler M., Casas S., Duarte J., Nomededeu J., and Sierra J. Chromosome 16 inversion-associated translocations in acute myeloid leukemia elucidated using a dual-color CBFB DNA probe. Cancer Genet Cytogenet 134 (2002) 142-144
15. Douet-Guilbert N., Arnaud B., Morel F., Le Bris M.J., and Braekeleer M.D. Cryptic 5′ MLL gene insertion in an X-chromosome in acute myeloblastic leukemia. Cancer Genet Cytogenet 157 (2005) 178-180